MedKoo Cat#: 130318 | Name: KVN93

Description:

WARNING: This product is for research use only, not for human or veterinary use.

KVN93 is a dual-specificity tyrosine phosphorylation-regulated kinase-1A (DYRK1A) inhibitor for the treatment of Alzheimer's disease and other neurological disorders.

Chemical Structure

KVN93
KVN93
CAS#N/A

Theoretical Analysis

MedKoo Cat#: 130318

Name: KVN93

CAS#: N/A

Chemical Formula: C27H33F3N6O3

Exact Mass: 546.2566

Molecular Weight: 546.60

Elemental Analysis: C, 59.33; H, 6.09; F, 10.43; N, 15.38; O, 8.78

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
KVN93; KVN 93; KVN-93
IUPAC/Chemical Name
(4-((4-(ethylamino)-3-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-6-yl)amino)-3-methoxyphenyl)(4-morpholinopiperidin-1-yl)methanone
InChi Key
FKRHOHUJMCOWDZ-UHFFFAOYSA-N
InChi Code
InChI=1S/C27H33F3N6O3/c1-3-31-21-15-23(34-25-24(21)19(16-32-25)27(28,29)30)33-20-5-4-17(14-22(20)38-2)26(37)36-8-6-18(7-9-36)35-10-12-39-13-11-35/h4-5,14-16,18H,3,6-13H2,1-2H3,(H3,31,32,33,34)
SMILES Code
O=C(C1=CC=C(NC2=CC(NCC)=C3C(NC=C3C(F)(F)F)=N2)C(OC)=C1)N4CCC(N5CCOCC5)CC4
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 546.60 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Lee HJ, Woo H, Lee HE, Jeon H, Ryu KY, Nam JH, Jeon SG, Park H, Lee JS, Han KM, Lee SM, Kim J, Kang RJ, Lee YH, Kim JI, Hoe HS. The novel DYRK1A inhibitor KVN93 regulates cognitive function, amyloid-beta pathology, and neuroinflammation. Free Radic Biol Med. 2020 Nov 20;160:575-595. doi: 10.1016/j.freeradbiomed.2020.08.030. Epub 2020 Sep 5. PMID: 32896600. 2. Pucelik B, Barzowska A, Dąbrowski JM, Czarna A. Diabetic Kinome Inhibitors-A New Opportunity for β-Cells Restoration. Int J Mol Sci. 2021 Aug 23;22(16):9083. doi: 10.3390/ijms22169083. PMID: 34445786; PMCID: PMC8396662.